Evidence map›Paper›PMID 22493704›Full record

ArticlePloS one2012

Suppressive effects on the immune response and protective immunity to a JEV DNA vaccine by co-administration of a GM-CSF-expressing plasmid in mice.

Hui Chen, Na Gao, Dongying Fan, Jiangman Wu, Junping Zhu, Jieqiong Li, Juan Wang, Yanlei Chen, Jing An

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Investigating Tick-borne Flaviviral-like Particles as a Delivery System for Gene Therapy.Current therapeutic research, clinical and experimental · 2018
    Article
  6. Article
  7. Inactivated genotype 1 Japanese encephalitis vaccine for swine.Clinical and experimental vaccine research · 2014
    Article
  8. Article
  9. Japanese encephalitis: the virus and vaccines.Human vaccines & immunotherapeutics · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Hui ChenDepartment of Microbiology, School of Basic Medical Sciences, Capital Medical University, Beijing, People's Republic of China.
Na Gao
Dongying Fan
Jiangman Wu
Junping Zhu
Jieqiong Li
Juan Wang
Yanlei Chen
Jing An
Capital Medical University · CNAlbany Medical Center Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a potential cytokine adjuvant of DNA vaccines, granulocyte-macrophage colony-stimulating factor (GM-CSF) has received considerable attention due to its essential role in the recruitment of antigen-presenting cells, differentiation and maturation of dendritic cells. However, in our recent study of a Japanese encephalitis virus (JEV) DNA vaccine, co-inoculation of a GM-CSF plasmid dramatically suppressed the specific IgG response and resulted in decreased protection against JEV challenge. It is known that GM-CSF has been used in clinic to treat neutropenia for repopulating myeloid cells, and as an adjuvant in vaccine studies; it has shown various effects on the immune response. Therefore, in this study, we characterized the suppressive effects on the immune response to a JEV DNA vaccine by the co-administration of the GM-CSF-expressing plasmid and clarified the underlying mechanisms of the suppression in mice. Our results demonstrated that co-immunization with GM-CSF caused a substantial dampening of the vaccine-induced antibody responses. The suppressive effect was dose- and timing-dependent and likely related to the immunogenicity of the antigen. The suppression was associated with the induction of immature dendritic cells and the expansion of regulatory T cells but not myeloid-derived suppressor cells. Collectively, our findings not only provide valuable information for the application of GM-CSF in clinic and using as a vaccine adjuvant but also offer further insight into the understanding of the complex roles of GM-CSF.

Indexed as

Adjuvants, ImmunologicAnimalsAntibodies, ViralCell ProliferationDendritic CellsEncephalitis, JapaneseEncephalitis Virus, JapaneseFemaleGranulocyte-Macrophage Colony-Stimulating FactorImmunity, HumoralMiceMice, Inbred BALB CPlasmidsT-Lymphocytes, RegulatoryVaccines, DNAViral VaccinesAdjuvants, ImmunologicAntibodies, ViralGranulocyte-Macrophage Colony-Stimulating FactorVaccines, DNAViral Vaccines

Identifiers

PMID22493704
PMCPMC3321030
OpenAlexW2048184935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.